Treatment · March 26, 2026
FDA Approves First Therapy for Ultra Rare Rapid Aging Disease Progeria
February FDA developments including kinase inhibitors, GLP-1 treatments, and new approval pathways represent important therapeutic...
Breakthrough · March 20, 2026
CRISPR Gene Editing Saves Infant in Pioneering One-Off Treatment for Rare Disease
Top medical advances of 2025 bring renewed optimism for treating previously intractable diseases....